Bio-Path Holdings Inc. (NASDAQ: BPTH) is 110.86% higher on its value in year-to-date trading and has touched a low of $2.92 and a high of $24.34 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BPTH stock was last observed hovering at around $7.60 in the last trading session, with the day’s loss setting it -0.22% off its average median price target of $10.00 for the next 12 months. It is also 26.2% off the consensus price target high of $10.00 offered by 1 analysts, but current levels are 26.2% higher than the price target low of $10.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $7.38, the stock is 24.38% and 57.10% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.89 million and changing -2.89% at the moment leaves the stock 61.12% off its SMA200. BPTH registered 15.49% gain for a year compared to 6-month gain of 86.36%. The firm has a 50-day simple moving average (SMA 50) of $5.18 and a 200-day simple moving average (SMA200) of $4.27.
The stock witnessed a 70.44% loss in the last 1 month and extending the period to 3 months gives it a 122.29%, and is -17.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.57% over the week and 15.23% over the month.
Distance from 52-week low is 152.71% and -69.68% from its 52-week high.
Bio-Path Holdings Inc. (BPTH) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Bio-Path Holdings Inc. (BPTH) is a “Buy”. 1 analysts offering their recommendations for the stock, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Bio-Path Holdings Inc. is expected to release its quarterly report on 05/20/2021 and quarterly earnings per share for the current quarter are estimated at -$0.78.The EPS is expected to grow by 77.50% this year.
Bio-Path Holdings Inc. (BPTH) Top Institutional Holders
18 institutions hold shares in Bio-Path Holdings Inc. (BPTH), with 46.42k shares held by insiders accounting for 1.02% while institutional investors hold 7.85% of the company’s shares. The shares outstanding are 4.54M, and float is at 4.50M with Short Float at 5.59%. Institutions hold 7.77% of the Float.
The top institutional shareholder in the company is Vanguard Group, Inc. (The) with over 96760.0 shares valued at $0.34 million. The investor’s holdings represent 1.39% of the BPTH Shares outstanding. As of Dec 30, 2020, the second largest holder is Renaissance Technologies, LLC with 77587.0 shares valued at $0.27 million to account for 1.12% of the shares outstanding. The other top investors are Blackrock Inc. which holds 59929.0 shares representing 0.86% and valued at over $0.21 million, while Geode Capital Management, LLC holds 0.49% of the shares totaling 34189.0 with a market value of $0.12 million.
Bio-Path Holdings Inc. (BPTH) Insider Activity
A total of 0 insider transactions have happened at Bio-Path Holdings Inc. (BPTH) in the last six months, with sales accounting for 0 and purchases happening 0 times.